We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-0.87%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$46.4B
AUM Growth
+$701M
(+1.5%)
Cap. Flow
+$2.34B
Cap. Flow
% of AUM
5.06%
Top 10 Holdings %
Top 10 Hldgs %
14.53%
Holding
2,237
New
170
Increased
888
Reduced
909
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$197M |
| 2 |
Deckers Outdoor
DECK
|
+$179M |
| 3 |
DexCom
DXCM
|
+$156M |
| 4 |
Teradyne
TER
|
+$154M |
| 5 |
ExxonMobil
XOM
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$163M |
| 2 |
Wingstop
WING
|
+$130M |
| 3 |
ServiceNow
NOW
|
+$108M |
| 4 |
GoDaddy
GDDY
|
+$94.2M |
| 5 |
Vertiv
VRT
|
+$80M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.5% |
| 2 | Healthcare | 16.86% |
| 3 | Financials | 13.55% |
| 4 | Consumer Discretionary | 9.41% |
| 5 | Industrials | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
First Busey Corp
BUSE
$2.52B
| $19.8K | ﹤0.01% |
916
-939
| -51% | -$21.8K |
|
|
MITT
1727
TPG Mortgage Investment Trust
MITT
$204M
| $19.7K | ﹤0.01% |
2,696
+1,219
| +83% | +$8.66K |
|
1728
KRONOS Worldwide
KRO
$941M
| $19.5K | ﹤0.01% |
2,609
| – | – |
|
1729
Group 1 Automotive
GPI
$3.28B
| $19.5K | ﹤0.01% |
51
| – | – |
|
1730
Archer Aviation
ACHR
$4.21B
| $19.4K | ﹤0.01% |
+2,732
| New | +$24.2K |
|
|
ETNB
1731
DELISTED
89bio
ETNB
| $19K | ﹤0.01% |
2,613
-3,670
| -58% | -$32.1K |
|
1732
Cullinan Oncology
CGEM
$1.32B
| $18.6K | ﹤0.01% |
2,458
-1,344
| -35% | -$12.9K |
|
1733
Nuvation Bio
NUVB
$2.04B
| $18.6K | ﹤0.01% |
10,556
-7,883
| -43% | -$17.9K |
|
1734
ING
ING
$105B
| $18.5K | ﹤0.01% |
946
+733
| +344% | +$13K |
|
1735
Equity Bancshares
EQBK
$1.03B
| $18.5K | ﹤0.01% |
470
-18,145
| -97% | -$761K |
|
1736
Kontoor Brands
KTB
$3.66B
| $18.4K | ﹤0.01% |
287
-495
| -63% | -$38.4K |
|
1737
Diodes
DIOD
$4.16B
| $18.3K | ﹤0.01% |
425
-462
| -52% | -$24.9K |
|
1738
IES Holdings
IESC
$12.4B
| $18.3K | ﹤0.01% |
222
-232
| -51% | -$24.2K |
|
1739
WisdomTree
WT
$3.35B
| $18.2K | ﹤0.01% |
2,045
-2,660
| -57% | -$24.8K |
|
1740
FIVE9
FIVN
$2.47B
| $18.1K | ﹤0.01% |
+667
| New | +$24.5K |
|
1741
Progyny
PGNY
$2.13B
| $18.1K | ﹤0.01% |
810
-1,076
| -57% | -$23.2K |
|
1742
Collegium Pharmaceutical
COLL
$711M
| $17.9K | ﹤0.01% |
601
-2,466
| -80% | -$75.4K |
|
1743
American Eagle Outfitters
AEO
$2.48B
| $17.8K | ﹤0.01% |
1,533
-2,375
| -61% | -$33.9K |
|
|
INZY
1744
DELISTED
Inozyme Pharma
INZY
| $17.5K | ﹤0.01% |
19,191
+14,095
| +277% | +$19.5K |
|
1745
Allogene Therapeutics
ALLO
$594M
| $17.3K | ﹤0.01% |
11,828
-11,543
| -49% | -$21.8K |
|
1746
Intellia Therapeutics
NTLA
$1.59B
| $17.2K | ﹤0.01% |
2,418
-1,427
| -37% | -$14.4K |
|
1747
United Parks & Resorts
PRKS
$1.63B
| $17.2K | ﹤0.01% |
378
-599
| -61% | -$30.9K |
|
1748
Green Brick Partners
GRBK
$2.89B
| $17.1K | ﹤0.01% |
293
-387
| -57% | -$22.9K |
|
1749
Arcus Biosciences
RCUS
$3.1B
| $16.8K | ﹤0.01% |
2,143
-750
| -26% | -$8.7K |
|
1750
Red Violet
RDVT
$1.22B
| $16.8K | ﹤0.01% |
447
+432
| +2,880% | +$16.3K |
|
Similar funds
Federated Hermes's Q1 2025 Portfolio in Review
As of Q1 2025, Federated Hermes held 2,237 positions worth $46.4B, up 1.5% from $45.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.34B of net new capital in Q1 2025, opening 170 new positions and adding to 888 existing holdings. Its largest new stake was Zscaler: 283,095 shares worth $56.2M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $163M trimmed.
- Federated Hermes's largest Q1 2025 buy was Zscaler: 283,095 shares worth $56.2M.
- Federated Hermes added most to Amgen in Q1 2025, an estimated $197M increase.
- Federated Hermes's biggest Q1 2025 reduction was Gilead Sciences, cutting an estimated $163M.
- Federated Hermes fully exited New Fortress Energy in Q1 2025, selling an estimated $31.4M.
- Federated Hermes's ten largest holdings make up 15% of its $46.4B portfolio in Q1 2025.
- Federated Hermes opened 170 new positions and closed 187 in Q1 2025.
- Federated Hermes's portfolio value rose 1.5% quarter-over-quarter to $46.4B.
Based on Federated Hermes's 13F filing for Q1 2025, filed 8 May 2025.